News
CTKB
5.92
-0.67%
-0.04
Weekly Report: what happened at CTKB last week (0408-0412)?
Weekly Report · 5d ago
Is it a Good Idea to Invest in ADMA Biologics (ADMA) Stock Now?
NASDAQ · 04/09 15:07
Weekly Report: what happened at CTKB last week (0401-0405)?
Weekly Report · 04/08 09:15
Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence
Bio-Techne is a life science tools and services company focused on the development and sale of reagents and consumables for life science research. The company's focus on the stable and lucrative life science market has led to above-average growth and profitability compared to diagnostic companies. Bio- techne has exhibited strong financial performance, with high profit margins and low leverage. Healthcare is a strong sector for secular growth, but life science is more stable than diagnostics.
Seeking Alpha · 04/04 12:43
New Strong Buy Stocks for April 2nd
NASDAQ · 04/02 11:05
Weekly Report: what happened at CTKB last week (0325-0329)?
Weekly Report · 04/01 09:15
CTKB Stock Earnings: Cytek Biosciences Beats Revenue for Q4 2023
Cytek Biosciences reported earnings per share of 4 cents. The company reported revenue of $58.23 million. This was 2.92% better than the analyst estimate of $56.58 million for the quarter. The stock was down 2.7% in the after-hours session.
Investorplace · 03/27 15:53
Weekly Report: what happened at CTKB last week (0318-0322)?
Weekly Report · 03/25 09:14
Optimistic Outlook: Cytek Biosciences Poised for Growth with New CFO Appointment
TipRanks · 03/21 21:05
Revvity: Enter Now As Reorganization Takes Shape
Revvity, Inc. Is a major laboratory instrument and service provider to the healthcare industry. The company has historically underperformed compared to its peers in terms of profit generation and growth. Revvity has implemented a business restructuring plan and aims to drive differentiation through inorganic investments in high-margin areas. Over the past 20 years the company has returned 10.5% per year for investors.
Seeking Alpha · 03/21 15:27
Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader
Cytek Biosciences is a leading cellular analysis instrument maker with a focus on the Aurora flow cytometry platform. Despite a downturn in the healthcare market, Cytek has maintained revenue growth above 15% since IPO. Cytek's technological advantage, broadening ecosystem, and potential in the clinical and biopharma space contribute to the positive outlook.
Seeking Alpha · 03/20 08:33
Cytek Biosciences, Inc.: Current report
Press release · 03/19 21:20
Cytek Biosciences Announces CFO Transition and New Appointment
TipRanks · 03/19 21:12
Cytek Biosciences appoints CFO
Healthcare Cytek Biosciences appoints CFO. William McCombe has served as CFO at Velo3D, a metal 3D printing systems company. Cell analysis solutions company cytek bioscience appoints william mccombe as cfo.
Seeking Alpha · 03/19 12:26
*Cytek Biosciences Backs FY24 Rev $203M-$213M >CTKB
Dow Jones · 03/19 12:08
*Cytek Biosciences Sees Positive Net Income for FY24, Assuming No Change in Currency Exchange Rates >CTKB
Dow Jones · 03/19 12:08
*Cytek Biosciences: McCombe Succeeds Patrik Jeanmonod, Who Was Named Head of Corporate Development Analytics >CTKB
Dow Jones · 03/19 12:07
Cytek Biosciences Names William McCombe Chief Financial Officer; Reaffirms 2024 Revenue Outlook Of $203M-$213M Vs $207.86M Est.
Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outlook. William (Bill) McCombe has been appointed chief financial officer of the company effective immediately. Cytek also reaffirms its full year 2024 revenue guidance of $203 million to $213 million.
Benzinga · 03/19 12:06
*Cytek Biosciences Names William McCombe Chief Fincl Officer >CTKB
Dow Jones · 03/19 12:01
*Cytek Biosciences Reaffirms 2024 Outlook >CTKB
Dow Jones · 03/19 12:01
More
Webull provides a variety of real-time CTKB stock news. You can receive the latest news about Cytek Biosciences, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About CTKB
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion reagent cocktail preparation system; the flow cytometer and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Cytek Northern Lights systems are flow cytometers that deliver high-resolution, high-content, and high-sensitivity cell analysis. Its Cytek Aurora CS is a cell sorter that leverages the detection and sensitivity capabilities of its FSP technology to isolate living cell populations from lower to higher complexity panels beyond 40 biomarkers.